Biggest News Aggregation in the World
📰 Bryan Wahl News

Bryan Wahl News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bryan Wahl. Real-time updates on events, politics, business and more.

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $49.88 Consensus Price Target from Brokerages

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight brokerages that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price […]
United States Bryan Wahl Bobakr Azamian Artisan Partners Limited Partnership Hedge Funds Weigh In On Tarsus Pharmaceuticals Securities Exchange Commission

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Recommendation of "Moderate Buy" by Analysts

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has received an average recommendation of “Moderate Buy” from the eight analysts that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month price objective among brokerages […]
United States Bobakr Azamian Bryan Wahl Vanguard Group Inc Goldman Sachs Group Tarsus Pharmaceuticals Trading Down

abrdn plc Buys New Shares in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)

Abrdn plc purchased a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 72,032 shares of the company’s stock, valued at approximately $1,459,000. Several other hedge funds have also recently made changes to their positions in TARS. RTW Investments LP boosted its position […]
United States Aziz Mottiwala Bryan Wahl Allspring Global Investments Holdings Jefferies Financial Group Goldman Sachs Group

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight research firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month […]
United States Bobakr Azamian Bryan Wahl Zurcher Kantonalbank Zurich Cantonalbank Goldman Sachs Group News Ratings For Tarsus Pharmaceuticals Daily
Source: wkrb13.com

Tarsus Pharmaceuticals (NASDAQ:TARS) Announces Earnings Results

Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) posted its earnings results on Tuesday. The company reported ($1.31) earnings per share for the quarter, beating the consensus estimate of ($1.37) by $0.06, MarketWatch Earnings reports. The company had revenue of $13.08 million for the quarter, compared to analysts’ expectations of $4.63 million. During the same period […]
Diannec Whitfield Bryan Wahl Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Tarsus Pharmaceuticals Trading Down Blackrock Inc
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Up 6.9%

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report)’s stock price was up 6.9% during trading on Monday . The stock traded as high as $25.14 and last traded at $25.09. Approximately 256,180 shares changed hands during mid-day trading, a decline of 60% from the average daily volume of 644,086 shares. The stock had previously closed […]
Bryan Wahl Bobakr Azamian Hedge Funds Weigh In On Tarsus Pharmaceuticals Tarsus Pharmaceuticals News Ratings For Tarsus Pharmaceuticals Daily Tarsus Pharmaceuticals Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science